🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Differin gel

Found 28 matching trials

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

PHASE3

To evaluate the therapeutic equivalence of topical Adapalene Gel, 0.1 % and...

Status

Withdrawn

Location

Multiple Locations

Start Date

2020-07

Trial ID

NCT04329403

Treatments Being Tested

Adapalene 0.1% Gel Differin 0.1% Topical Gel Placebo

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical ...

Status

Completed

Location

L.T.M. Medical College & General Hospital

Start Date

2009-03

Trial ID

NCT01095640

Treatments Being Tested

adapalene 0.3% topical gel

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne

PHASE4

The objectives of this clinical trial are to compare the quality of life of...

Status

Completed

Location

Hospital Abente y Lago in La Coruna

Start Date

2006-11

Trial ID

NCT00807014

Treatments Being Tested

Duac Gel Differin gel

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

EARLY_PHASE1

To demonstrate therapeutic equivalence and safety of adapalene gel 0.1% (Ta...

Status

Completed

Location

Catawba Research, LLC

Start Date

2020-05-18

Trial ID

NCT04797793

Treatments Being Tested

Adapalene Gel 0.1%Placebo Control Differin® Gel (Adapalene 0.1%, Galderma)

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

PHASE1

This study will investigate the pharmacokinetics, safety and tolerability o...

Status

Withdrawn

Location

Multiple Locations

Start Date

2013-01

Trial ID

NCT01425320

Treatments Being Tested

Fixed Combination dapsone/adapalene Formulation A Gel Fixed Combination dapsone/adapalene Formulation B Gel dapsone 5% gel adapalene 0.3% gel

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

PHASE4

To determine the efficacy and safety of 12 weeks of treatment with Differin...

Status

Completed

Location

Therapeutics Clinical Research

Start Date

2006-02

Trial ID

NCT00469755

Treatments Being Tested

Adapalene Gel, 0.1%Tazarotene Cream, 0.1%Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%

An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne

PHASE3

Acne is an inflammation of sebaceous glands and follicles. Applying topical...

Status

Completed

Location

Siriraj Hospital Mahidol Univeristy

Start Date

2014-07

Trial ID

NCT02173054

Treatments Being Tested

Adapalene gel with Eucerin Adapalene gel Adapalene gel with placebo moisturizer

Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins

PHASE4

This is a single-center study, randomized, Investigator/Evaluator-blinded b...

Status

Completed

Location

national Skin Center

Start Date

2008-12

Trial ID

NCT00971282

Treatments Being Tested

adapalen 0.1%Cetaphil®

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin

PHASE4

The purpose of this study is to assess the effect of Skinoren® 15% gel comp...

Status

Completed

Location

Clinic for Dermatology and Vereology, Central Hospital Magdeburg

Start Date

2011-08

Trial ID

NCT01387048

Treatments Being Tested

skinoren differin skinoren

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

PHASE4

Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared wit...

Status

Terminated

Location

Multiple Locations

Start Date

2007-10

Trial ID

NCT00829049

Treatments Being Tested

Tazarotene Cream 0.1%Adapalene

Previous Next